Insider Trading activities of Avadel Pharmaceuticals Plc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avadel Pharmaceuticals Plc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avadel Pharmaceuticals Plc since year 2005. Table 2 shows the detailed insider transactions of Avadel Pharmaceuticals Plc since 2005. The reporting company's ticker symbol is AVDL. The reporting company's CIK number is 1012477.
The total value of stock buying since 2005 is $2,938,523.
The total value of stock sales since 2005 is $5,643,799.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Avadel Pharmaceuticals Plc (AVDL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 5,000 $44,295 0 $0 0 $0
2017-11 0 $0 254,265 $2,377,632 0 $0
2017-09 50,755 $480,818 0 $0 0 $0
2017-06 0 $0 287,560 $3,064,417 0 $0
2017-05 33,513 $330,326 0 $0 0 $0
2016-11 22,000 $237,144 0 $0 0 $0
2016-09 12,000 $163,430 15,000 $201,750 0 $0
2016-08 25,000 $346,480 0 $0 0 $0
2016-03 128,000 $1,336,030 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Avadel Pharmaceuticals Plc insiders (AVDL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-07 Anderson Michael S (Chief Executive Officer) Buy 5,000 8.86 44,295
2017-11-27 Stapleton Craig R Sale 254,265 9.35 2,377,632
2017-09-21 Thornton Peter J. Buy 5,155 9.74 50,214
2017-09-14 Hatten Sandra L (See Remarks) Buy 2,100 9.36 19,653
2017-09-13 Thompson Phillandas T. (See Remarks) Buy 5,000 9.36 46,800
2017-09-13 Hatten Sandra L (See Remarks) Buy 500 9.35 4,673
2017-09-12 Hatten Sandra L (See Remarks) Buy 3,400 9.17 31,178
2017-09-12 Divis Greg J (See Remarks) Buy 10,600 9.32 98,760
2017-09-12 Stapleton Craig R Buy 20,000 9.52 190,360
2017-09-12 Anderson Michael S (Chief Executive Officer) Buy 4,000 9.79 39,180
2017-06-23 Kotler Kevin Sale 161,000 10.60 1,706,600
2017-06-22 Kotler Kevin Sale 100,000 10.80 1,080,000
2017-06-15 Cerutti Guillaume Sale 26,560 10.46 277,817
2017-05-22 Stapleton Craig R Buy 16,900 9.76 164,944
2017-05-19 Stapleton Craig R Buy 3,100 9.83 30,473
2017-05-19 Anderson Michael S (Chief Executive Officer) Buy 2,500 10.00 25,000
2017-05-18 Stapleton Craig R Buy 11,013 9.98 109,909
2016-11-29 Stapleton Craig R Buy 10,000 10.85 108,500
2016-11-28 Stapleton Craig R Buy 10,000 10.74 107,370
2016-11-21 Anderson Michael S (Chief Executive Officer) Buy 2,000 10.64 21,274
2016-09-22 Fildes Francis Sale 15,000 13.45 201,750
2016-09-02 Anderson Michael S (Chief Executive Officer) Buy 2,000 14.12 28,240
2016-09-01 Stapleton Craig R Buy 10,000 13.52 135,190
2016-08-26 Stapleton Craig R Buy 20,000 13.75 275,000
2016-08-22 Anderson Michael S (Chief Executive Officer) Buy 5,000 14.30 71,480
2016-03-22 Thompson Phillandas T. (See Remarks) Buy 10,000 11.10 111,030
2016-03-18 Hatten Sandra L (Sr. VP, Quality & Reg Affairs) Buy 3,000 11.01 33,030
2016-03-18 Anderson Michael S (Chief Executive Officer) Buy 5,000 11.04 55,220
2016-03-14 Stapleton Craig R Buy 100,000 10.39 1,039,400
2016-03-14 Anderson Michael S (Chief Executive Office) Buy 10,000 9.73 97,350

Insider trading activities including stock purchases, stock sales, and option exercises of AVDL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avadel Pharmaceuticals Plc (symbol AVDL, CIK number 1012477) see the Securities and Exchange Commission (SEC) website.